GAMMA Investing’s Quoin Pharmaceuticals QNRX Stock Holding History

GAMMA Investing’s Portfolio QNRX Stock Details QNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.13K	Sell	439 -1,281	-74%	-$6.91K	﹤0.01%	3723
2026 Q1	$11.4K	Sell	1,720 -364	-17%	-$3.3K	﹤0.01%	3004
2025 Q4	$30.1K	Buy	2,084 +1,806	+650%	+$24.6K	﹤0.01%	2391
2025 Q3	$2K	Buy	278 +38	+16%	+$296	﹤0.01%	3450
2025 Q2	$2.21K	Buy	+240	New	+$1.84K	﹤0.01%	3376

Other funds holding QNRX

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

GAMMA Investing's QNRX Position: Q2 2026 in Review

GAMMA Investing reduced its Quoin Pharmaceuticals (QNRX) stake by 74% in Q2 2026, selling an estimated $6.91K and leaving 439 shares worth $2.13K. The position accounts for ﹤0.01% of the portfolio, ranked #3723.

GAMMA Investing first reported a position in QNRX in Q2 2025 and has held it in 5 quarters since. The position peaked at $30.1K in Q4 2025. 2 funds tracked by Wall St. Rank hold QNRX as of Q2 2026.

GAMMA Investing held 439 shares of Quoin Pharmaceuticals worth $2.13K as of Q2 2026.
GAMMA Investing sold 1,281 Quoin Pharmaceuticals shares in Q2 2026, an estimated $6.91K.
Quoin Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3723 holding.
GAMMA Investing first reported a position in Quoin Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
GAMMA Investing's Quoin Pharmaceuticals position peaked at $30.1K in Q4 2025.
2 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.